ISIN | CH0226274204 |
---|---|
Valor Number | 22627420 |
Bloomberg Global ID | SWEUAH SW |
Fund Name | UBS ETF (CH) - UBS MSCI Switzerland hEUR ETF EUR dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The UBS ETF (CH) – MSCI Switzerland 100% hedged to EUR is an exchange traded fund incorporated in Switzerland. The objective of the Fund is to deliver the net total return performance of the MSCI Switzerland 100% hedged to EUR and allow intraday trading. |
Peculiarities |
Current Price * | 28.56 EUR | 12.09.2025 |
---|---|---|
Previous Price * | 28.76 EUR | 11.09.2025 |
52 Week High * | 29.17 EUR | 03.03.2025 |
52 Week Low * | 24.42 EUR | 09.04.2025 |
NAV * | 28.56 EUR | 12.09.2025 |
Issue Price * | 28.56 EUR | 12.09.2025 |
Redemption Price * | 28.56 EUR | 12.09.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 121,105,363 | |
Unit/Share Assets *** | 121,105,363 | |
Trading Information SIX |
YTD Performance | +10.77% |
31.12.2024 - 12.09.2025
31.12.2024 12.09.2025 |
---|---|---|
YTD Performance (in CHF) | +10.18% |
31.12.2024 - 12.09.2025
31.12.2024 12.09.2025 |
1 month | +2.91% |
12.08.2025 - 12.09.2025
12.08.2025 12.09.2025 |
3 months | +0.25% |
12.06.2025 - 12.09.2025
12.06.2025 12.09.2025 |
6 months | -0.35% |
12.03.2025 - 12.09.2025
12.03.2025 12.09.2025 |
1 year | +8.44% |
12.09.2024 - 12.09.2025
12.09.2024 12.09.2025 |
2 years | +22.87% |
12.09.2023 - 12.09.2025
12.09.2023 12.09.2025 |
3 years | +27.32% |
12.09.2022 - 12.09.2025
12.09.2022 12.09.2025 |
5 years | +38.58% |
14.09.2020 - 12.09.2025
14.09.2020 12.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 12.09.2025 |
Novartis AG Registered Shares | 13.08% | |
---|---|---|
Nestle SA | 12.94% | |
Roche Holding AG | 12.76% | |
UBS Group AG Registered Shares | 6.92% | |
ABB Ltd | 6.06% | |
Zurich Insurance Group AG | 5.73% | |
Compagnie Financiere Richemont SA Class A | 5.45% | |
Swiss Re AG | 2.86% | |
Lonza Group Ltd | 2.67% | |
Holcim Ltd | 2.35% | |
Last data update | 10.09.2025 |
TER | 0.26% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.23% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |